Research from the lab of Jana Shen looks at a mutation causing diminished effectiveness of Paxlovid.

James Polli, PhD, leads multiple intercampus research centers in regulatory science and drug quality.

SOP task force transforms input into vigorous initiative to advance equity, diversity, and inclusion.

The daylong event featured career panels and networking opportunities.

The PhD and MS in PSC and PhD in PHSR programs have changed leadership.

Michel is an internationally recognized researcher and has been involved in all of the School’s educational aspects.

Since June, Michel has served as interim dean and was previously chair of the Department of Pharmaceutical Sciences and associate dean for graduate programs.

Shapiro and UMSOM’s Jeffrey Hasday, MD, honored for discovery of a novel class of drugs that selectively inhibits an enzyme’s role in promoting disease-causing inflammation and has been licensed to GEn1E Lifesciences.

Former dean receives the Hartmut Derendorf Mentorship in Clinical Pharmacology Award.

When Natalie D. Eddington stepped down as dean this spring, it marked the end of a more than 15-year tenure spent in service to academic pharmacy filled with laudable accomplishments.

Six major drug agencies participated in workshop.

Nearly 1,000 students are enrolled in the School’s 10 programs.